Annovis Bio Inc (ANVS): No, phase2b 40 PD patient trial.

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	21
Boards Moderated	0
Alias Born	01/25/2021

MZlu

Re: McMagyar post# 170

Wednesday, 10/06/2021 12:44:16 AM

Wednesday, October 06, 2021 12:44:16 AM

No, phase2b 40 PD patient trial.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ANVS News

Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:15:54 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:09:07 PM
IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024 • GlobeNewswire Inc. • 08/05/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 12:05:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:05:43 PM
Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News • IH Market News • 07/08/2024 10:37:52 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 10:05:38 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 09:00:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:32:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:05:24 PM
Annovis Announces New Publication in a Peer-Reviewed Journal • GlobeNewswire Inc. • 05/21/2024 11:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:05:46 PM
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:11:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:03:33 PM
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 09:12:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:11:19 PM
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders • GlobeNewswire Inc. • 05/06/2024 11:30:00 AM
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease • GlobeNewswire Inc. • 04/29/2024 02:10:00 PM
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
US Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters… • IH Market News • 02/28/2024 12:08:14 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/12/2024 07:00:23 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:05:20 PM

More ANVS News

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover